Loading...
Loading...
India's clotrimazole imports from CANADA total $408 across 1 shipments from 1 foreign suppliers. NewLife Medicals (USA). Inc leads with $408 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include JAMP INDIA PHARMACEUTICALS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for clotrimazole — a concentrated sourcing relationship with select suppliers from CANADA.

NewLife Medicals (USA). Inc is the leading Clotrimazole supplier from CANADA to India, with import value of $408 across 1 shipments. The top 5 suppliers — NewLife Medicals (USA). Inc — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NewLife Medicals (USA). Inc | $408 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | JAMP INDIA PHARMACEUTICALS PRIVATE LIMITED | $408 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Clotrimazole suppliers from CANADA to India include NewLife Medicals (USA). Inc. The leading supplier is NewLife Medicals (USA). Inc with import value of $408 USD across 1 shipments. India imported Clotrimazole worth $408 USD from CANADA in total across 1 shipments.
India imported Clotrimazole worth $408 USD from CANADA across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Clotrimazole sourced from CANADA include JAMP INDIA PHARMACEUTICALS PRIVATE LIMITED. The largest buyer is JAMP INDIA PHARMACEUTICALS PRIVATE LIMITED with $408 in imports across 1 shipments.
The total value of Clotrimazole imports from CANADA to India is $408 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists